Takeda’s HYQVIA reduces CIDP relapse rates, Phase 3 trial reveals
Takeda Pharmaceutical Company has disclosed successful outcomes from its critical Phase 3 ADVANCE-CIDP 1 trial, focused on evaluating HYQVIA as a maintenance therapy for adults ... Read More
Alkermes to acquire Boston-based neuroscience company Rodin Therapeutics
Alkermes acquisition of Rodin Therapeutics : Irish biopharma company Alkermes has agreed to acquire Boston-based neuroscience company Rodin Therapeutics in a deal worth up to ... Read More
Basics of Human Body & different Organ Systems
Human Body Our Human Body represents the entire structure of the human organism. It consists of trillions of cells that are organised biologically to form ... Read More